AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 32.74 |
Market Cap | 10.42B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.74 |
PE Ratio (ttm) | -21.28 |
Forward PE | n/a |
Analyst | Buy |
Ask | 38.8 |
Volume | 786,702 |
Avg. Volume (20D) | 1,454,052 |
Open | 36.53 |
Previous Close | 35.78 |
Day's Range | 36.26 - 37.45 |
52-Week Range | 31.16 - 40.89 |
Beta | undefined |
About APG
APi Group Corporation provides safety, specialty, and industrial services in North America, Europe, Australia, and the Asian-Pacific. It operates through three segments: Safety Services, Specialty Services, and Industrial Services. The Safety Services segment offers safety solutions focusing on end-to-end integrated occupancy systems, such as fire protection solutions; heating, ventilation, and air conditioning solutions; and entry systems, which...
Analyst Forecast
According to 8 analyst ratings, the average rating for APG stock is "Buy." The 12-month stock price forecast is $44, which is an increase of 18.82% from the latest price.
Next Earnings Release
Analysts project revenue of $1.84B, reflecting a 4.60% YoY growth and earnings per share of 0.51, making a 15.91% increase YoY.
4 weeks ago · seekingalpha.com
APi Group: Expecting Growth To Accelerate And Adj EBITDA Margin To ExpandI reiterate a buy rating for APG due to strong market share potential, growth acceleration, and adj EBITDA margin expansion prospects for FY25 and beyond. APG's solid demand trend is evidenced by a $3...
2 months ago · seekingalpha.com
Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic DermatitisApogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing and potential applications in asthma, COPD, and psoriasis. APGE's investigational pipeline includes AP...
2 months ago · seekingalpha.com
Genuine Parts Company: Rating Downgrade On Weak Near-Term OutlookI downgrade Genuine Parts Company stock from buy to hold due to poor 3Q24 performance and a weak macroeconomic outlook impacting both APG and IPG segments. 3Q24 results showed disappointing comparable...